ID   CDC7_HUMAN              Reviewed;         574 AA.
AC   O00311; O00558; Q5T5U5;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   05-OCT-2010, entry version 105.
DE   RecName: Full=Cell division cycle 7-related protein kinase;
DE            Short=CDC7-related kinase;
DE            Short=HsCdc7;
DE            Short=huCdc7;
DE            EC=2.7.11.1;
GN   Name=CDC7; Synonyms=CDC7L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver, and Testis;
RX   MEDLINE=97392464; PubMed=9250678; DOI=10.1093/emboj/16.14.4340;
RA   Sato N., Arai K., Masai H.;
RT   "Human and Xenopus cDNAs encoding budding yeast Cdc7-related kinases:
RT   in vitro phosphorylation of MCM subunits by a putative human homologue
RT   of Cdc7.";
RL   EMBO J. 16:4340-4351(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=98241510; PubMed=9573348; DOI=10.1016/S0378-1119(98)00094-8;
RA   Hess G.F., Drong R.F., Weiland K.L., Slightom J.L., Sclafani R.A.,
RA   Hollingsworth R.E.;
RT   "A human homolog of the yeast CDC7 gene is overexpressed in some
RT   tumors and transformed cell lines.";
RL   Gene 211:133-140(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RX   MEDLINE=98070749; PubMed=9405610; DOI=10.1073/pnas.94.26.14320;
RA   Jiang W., Hunter T.;
RT   "Identification and characterization of a human protein kinase related
RT   to budding yeast Cdc7p.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:14320-14325(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS PRO-23; VAL-99;
RP   TRP-112; LEU-162 AND ARG-441.
RG   NIEHS SNPs program;
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH DBF4.
RX   PubMed=10373557;
RA   Kumagai H., Sato N., Yamada M., Mahony D., Seghezzi W., Lees E.,
RA   Arai K., Masai H.;
RT   "A novel growth- and cell cycle-regulated protein, ASK, activates
RT   human Cdc7-related kinase and is essential for G1/S transition in
RT   mammalian cells.";
RL   Mol. Cell. Biol. 19:5083-5095(1999).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH DBF4B.
RX   MEDLINE=22060515; PubMed=12065429; DOI=10.1093/emboj/cdf290;
RA   Montagnoli A., Bosotti R., Villa F., Rialland M., Brotherton D.,
RA   Mercurio C., Berthelsen J., Santocanale C.;
RT   "Drf1, a novel regulatory subunit for human Cdc7 kinase.";
RL   EMBO J. 21:3171-3181(2002).
RN   [9]
RP   INTERACTION WITH DBF4B.
RX   PubMed=15668232; DOI=10.1074/jbc.M411653200;
RA   Yoshizawa-Sugata N., Ishii A., Taniyama C., Matsui E., Arai K.,
RA   Masai H.;
RT   "A second human Dbf4/ASK-related protein, Drf1/ASKL1, is required for
RT   efficient progression of S and M phases.";
RL   J. Biol. Chem. 280:13062-13070(2005).
RN   [10]
RP   INTERACTION WITH DBF4 AND DBF4B.
RX   PubMed=17062569; DOI=10.1074/jbc.M604457200;
RA   Tenca P., Brotherton D., Montagnoli A., Rainoldi S., Albanese C.,
RA   Santocanale C.;
RT   "Cdc7 is an active kinase in human cancer cells undergoing replication
RT   stress.";
RL   J. Biol. Chem. 282:208-215(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-27, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-503, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; TYR-508 AND SER-509,
RP   AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-162; MET-208; ASP-209; ARG-441;
RP   ILE-472 AND ALA-498.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Seems to phosphorylate critical substrates that regulate
CC       the G1/S phase transition and/or DNA replication. Can
CC       phosphorylates MCM2 and MCM3.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- SUBUNIT: Forms a complex with either DBF4/DBF4A or DBF4B, leading
CC       to the activation of the kinase activity.
CC   -!- INTERACTION:
CC       P11802:CDK4; NbExp=1; IntAct=EBI-374980, EBI-295644;
CC       P38936:CDKN1A; NbExp=1; IntAct=EBI-374980, EBI-375077;
CC       P42771:CDKN2A; NbExp=1; IntAct=EBI-374980, EBI-375053;
CC       Q7L590:MCM10; NbExp=1; IntAct=EBI-374980, EBI-374912;
CC       P25205:MCM3; NbExp=1; IntAct=EBI-374980, EBI-355153;
CC       O43913:ORC5L; NbExp=1; IntAct=EBI-374980, EBI-374928;
CC       Q9Y5N6:ORC6L; NbExp=1; IntAct=EBI-374980, EBI-374840;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=A number of isoforms may be produced;
CC       Name=1;
CC         IsoId=O00311-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family. CDC7 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdc7/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB003698; BAA19962.1; -; mRNA.
DR   EMBL; AF015592; AAC52080.1; -; mRNA.
DR   EMBL; AF005209; AAB97512.1; -; mRNA.
DR   EMBL; AY585721; AAS79323.1; -; Genomic_DNA.
DR   EMBL; AL355871; CAI14446.1; -; Genomic_DNA.
DR   EMBL; BC110526; AAI10527.1; -; mRNA.
DR   EMBL; BC110527; AAI10528.1; -; mRNA.
DR   EMBL; BC111044; AAI11045.1; -; mRNA.
DR   IPI; IPI00448121; -.
DR   RefSeq; NP_001127891.1; -.
DR   RefSeq; NP_001127892.1; -.
DR   RefSeq; NP_003494.1; -.
DR   UniGene; Hs.533573; -.
DR   ProteinModelPortal; O00311; -.
DR   IntAct; O00311; 7.
DR   MINT; MINT-1201209; -.
DR   STRING; O00311; -.
DR   PhosphoSite; O00311; -.
DR   PRIDE; O00311; -.
DR   Ensembl; ENST00000234626; ENSP00000234626; ENSG00000097046.
DR   Ensembl; ENST00000428239; ENSP00000393139; ENSG00000097046.
DR   Ensembl; ENST00000430031; ENSP00000407477; ENSG00000097046.
DR   GeneID; 8317; -.
DR   KEGG; hsa:8317; -.
DR   UCSC; uc001doe.1; human.
DR   CTD; 8317; -.
DR   GeneCards; GC01P091966; -.
DR   H-InvDB; HIX0028491; -.
DR   HGNC; HGNC:1745; CDC7.
DR   HPA; CAB002669; -.
DR   MIM; 603311; gene.
DR   PharmGKB; PA134879457; -.
DR   eggNOG; prNOG13989; -.
DR   HOGENOM; HBG713974; -.
DR   HOVERGEN; HBG003991; -.
DR   InParanoid; O00311; -.
DR   OMA; LCEKLRG; -.
DR   OrthoDB; EOG9GQSR5; -.
DR   PhylomeDB; O00311; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   Reactome; REACT_1538; Cell Cycle Checkpoints.
DR   Reactome; REACT_383; DNA Replication.
DR   NextBio; 31147; -.
DR   ArrayExpress; O00311; -.
DR   Bgee; O00311; -.
DR   CleanEx; HS_CDC7; -.
DR   Genevestigator; O00311; -.
DR   GermOnline; ENSG00000097046; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; EXP:Reactome.
DR   GO; GO:0000082; P:G1/S transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:HGNC.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0033261; P:regulation of S phase; IMP:HGNC.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    574       Cell division cycle 7-related protein
FT                                kinase.
FT                                /FTId=PRO_0000085763.
FT   DOMAIN       58    574       Protein kinase.
FT   NP_BIND      64     72       ATP (By similarity).
FT   ACT_SITE    177    177       Proton acceptor (By similarity).
FT   BINDING      90     90       ATP (By similarity).
FT   MOD_RES      16     16       Phosphoserine.
FT   MOD_RES      27     27       Phosphoserine.
FT   MOD_RES     503    503       Phosphothreonine.
FT   MOD_RES     508    508       Phosphotyrosine.
FT   MOD_RES     509    509       Phosphoserine.
FT   VARIANT      23     23       Q -> P (in dbSNP:rs13447459).
FT                                /FTId=VAR_019255.
FT   VARIANT      99     99       I -> V (in dbSNP:rs13447492).
FT                                /FTId=VAR_019256.
FT   VARIANT     112    112       G -> W (in dbSNP:rs13447493).
FT                                /FTId=VAR_019257.
FT   VARIANT     162    162       F -> L (in dbSNP:rs13447503).
FT                                /FTId=VAR_019258.
FT   VARIANT     208    208       I -> M (in dbSNP:rs34979509).
FT                                /FTId=VAR_040403.
FT   VARIANT     209    209       E -> D (in dbSNP:rs56327502).
FT                                /FTId=VAR_040404.
FT   VARIANT     441    441       K -> R (in dbSNP:rs13447539).
FT                                /FTId=VAR_019259.
FT   VARIANT     472    472       T -> I (in dbSNP:rs56381770).
FT                                /FTId=VAR_040405.
FT   VARIANT     498    498       S -> A (in dbSNP:rs35055915).
FT                                /FTId=VAR_040406.
FT   CONFLICT     89     89       L -> V (in Ref. 3; AAB97512).
SQ   SEQUENCE   574 AA;  63888 MW;  90D549BEE20AE583 CRC64;
     MEASLGIQMD EPMAFSPQRD RFQAEGSLKK NEQNFKLAGV KKDIEKLYEA VPQLSNVFKI
     EDKIGEGTFS SVYLATAQLQ VGPEEKIALK HLIPTSHPIR IAAELQCLTV AGGQDNVMGV
     KYCFRKNDHV VIAMPYLEHE SFLDILNSLS FQEVREYMLN LFKALKRIHQ FGIVHRDVKP
     SNFLYNRRLK KYALVDFGLA QGTHDTKIEL LKFVQSEAQQ ERCSQNKSHI ITGNKIPLSG
     PVPKELDQQS TTKASVKRPY TNAQIQIKQG KDGKEGSVGL SVQRSVFGER NFNIHSSISH
     ESPAVKLMKQ SKTVDVLSRK LATKKKAIST KVMNSAVMRK TASSCPASLT CDCYATDKVC
     SICLSRRQQV APRAGTPGFR APEVLTKCPN QTTAIDMWSA GVIFLSLLSG RYPFYKASDD
     LTALAQIMTI RGSRETIQAA KTFGKSILCS KEVPAQDLRK LCERLRGMDS STPKLTSDIQ
     GHASHQPAIS EKTDHKASCL VQTPPGQYSG NSFKKGDSNS CEHCFDEYNT NLEGWNEVPD
     EAYDLLDKLL DLNPASRITA EEALLHPFFK DMSL
//
